Clinical Trial Update: Stem Cell Transplantation for Hematological Malignancies [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports termination of a Phase 2/Phase 3 study evaluating stem cell transplantation for hematologic malignancies. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Leukemia, Lymphocytic, Acute, AML | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2013-02-13